{
    "clinical_study": {
        "@rank": "148064", 
        "arm_group": {
            "arm_group_label": "RoActemra/Actemra (tocilizumab)", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "This two part, multi-center, open-label, single-arm study will evaluate the efficacy and\n      safety of RoActemra/Actemra as a monotherapy or in combination with non-biologic disease\n      modifying antirheumatic drugs (DMARDs) in patients with moderate to severe rheumatoid\n      arthritis who have an inadequate response or are intolerant to non-biologic DMARDs or\n      biologic therapy. 162 mg RoActemra/Actemra will be administered once a week by subcutaneous\n      injection for up to 76 weeks."
        }, 
        "brief_title": "A Study Of RoActemra/Actemra (Tocilizumab) in Tocilizumab-Naive Patients With Rheumatoid Arthritis With Inadequate Response to Non-Biologic Disease-Modifying Antirheumatic Drugs (DMARDs) or Biologic Therapy", 
        "completion_date": {
            "#text": "November 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Rheumatoid Arthritis", 
        "condition_browse": {
            "mesh_term": [
                "Arthritis", 
                "Arthritis, Rheumatoid"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients > / = 18 years of age\n\n          -  Patients with a diagnosis of active RA according to the revised ACR criteria or\n             EULAR/ACR criteria and receiving outpatient treatment\n\n          -  Oral corticosteroids (< / = 10 mg/day prednisone or equivalent) nonsteroidal\n             anti-inflammatory drugs (NSAIDs), and permitted non-biologic DMARDs are allowed if on\n             a stable dose regimen for > / = 20 mm/h and swollen joint count (SJC) > / = 3 (based\n             on 44 joints)\n\n          -  Inadequate response (IR) to tumor necrosis factor, Abatacept and/or non-biological\n             disease-modifying antirheumatic drugs (DMARDs)\n\n        Exclusion Criteria:\n\n          -  Major surgery (including joint surgery) within 8 weeks prior to Screening or planned\n             major surgery within 6 months following Baseline\n\n          -  Rheumatic autoimmune disease other than RA; Secondary Sj\u00f6gren's syndrome with RA is\n             permitted.\n\n          -  Functional Class IV as defined by the ACR Classification of Functional Status in\n             Rheumatoid Arthritis\n\n          -  Diagnosis of juvenile idiopathic arthritis or juvenile RA and/or RA before the age of\n             16\n\n          -  Prior history of current inflammatory joint disease other than RA\n\n          -  Exposure to RoActemra/Actemra at any time prior to Baseline\n\n          -  Treatment with any investigational agent within 4 weeks of Screening\n\n          -  Previous treatment with any cell-depleting therapies, including investigational\n             agents or approved therapies or any alkylating agents such as chlorambucil, or with\n             total lymphoid irradiation\n\n          -  Treatment with IV gamma globulin, plasmapheresis within 6 months of Baseline\n\n          -  Intraarticular or parenteral corticosteroids within 4 weeks prior to Baseline\n\n          -  Immunization with a live/attenuated vaccine within 4 weeks prior to Baseline\n\n          -  History of severe allergic or anaphylactic reactions to human, humanized, or murine\n             monoclonal antibodies\n\n          -  Serious uncontrolled concomitant disease or other significant condition\n\n          -  History of diverticulitis, diverticulosis requiring antibiotic treatment, or chronic\n             ulcerative lower GI disease\n\n          -  Current or history of recurrent bacterial, viral, fungal, mycobacterial, or other\n             infections\n\n          -  Any infection requiring hospitalization or treatment with IV antibiotics within 4\n             weeks of Screening or oral antibiotics within 2 weeks of Screening\n\n          -  Active TB requiring treatment within the previous 3 years\n\n          -  Positive for hepatitis B or C\n\n          -  Primary or secondary immunodeficiency disorder\n\n          -  Active cancer, or cancer diagnosed within the previous 10 years (except for\n             non-melanoma skin cancer or carcinoma in situ of the cervix that has been treated of\n             excised and is considered resolved), or breast cancer diagnosed within the previous\n             20 years\n\n          -  History of alcohol, drug, or chemical abuse within 1 year prior to Screening\n\n          -  Neuropathies or other conditions that might interfere with pain evaluation"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "130", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 29, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02001987", 
            "org_study_id": "ML28693"
        }, 
        "intervention": {
            "arm_group_label": "RoActemra/Actemra (tocilizumab)", 
            "description": "162 mg administered once weekly by subcutaneous injection.", 
            "intervention_name": "tocilizumab [RoActemra/Actemra]", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Antirheumatic Agents"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "lastchanged_date": "May 19, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Belfort", 
                        "country": "France", 
                        "zip": "90016"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bordeaux", 
                        "country": "France", 
                        "zip": "33076"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Brest", 
                        "country": "France", 
                        "zip": "29609"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cahors", 
                        "country": "France", 
                        "zip": "46005"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Clermont-ferrand", 
                        "country": "France", 
                        "zip": "63003"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Echirolles", 
                        "country": "France", 
                        "zip": "38434"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "La Source", 
                        "country": "France", 
                        "zip": "45100"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Le Mans", 
                        "country": "France", 
                        "zip": "72037"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lille", 
                        "country": "France", 
                        "zip": "59037"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Limoges", 
                        "country": "France", 
                        "zip": "87042"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lyon cedex 3", 
                        "country": "France", 
                        "zip": "69437"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Marseille", 
                        "country": "France", 
                        "zip": "13274"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Marseille", 
                        "country": "France", 
                        "zip": "13285"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Metz Tessy", 
                        "country": "France", 
                        "zip": "74370"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Montpellier", 
                        "country": "France", 
                        "zip": "34295"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Montpellier", 
                        "country": "France", 
                        "zip": "34295"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Mulhouse", 
                        "country": "France", 
                        "zip": "68070"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nantes", 
                        "country": "France", 
                        "zip": "44035"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France", 
                        "zip": "75475"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France", 
                        "zip": "75571"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France", 
                        "zip": "75651"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rennes", 
                        "country": "France", 
                        "zip": "35203"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rouen", 
                        "country": "France", 
                        "zip": "76031"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "St Mande", 
                        "country": "France", 
                        "zip": "94163"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "St Priest En Jarez", 
                        "country": "France", 
                        "zip": "42277"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Thonon Les Bains", 
                        "country": "France", 
                        "zip": "74203"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Toulouse", 
                        "country": "France", 
                        "zip": "31059"
                    }
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "1", 
        "official_title": "A Multicenter Open-Label Study to Evaluate the Efficacy, Safety and Tolerability of Subcutaneous Tocilizumab in Tocilizumab-Naive Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to Current Non-Biologic DMARD and/or Biologic Therapy", 
        "overall_contact": {
            "email": "global.rochegenentechtrials@roche.com", 
            "last_name": "Reference Study ID Number: ML28693 www.roche.com/about_roche/roche_worldwide.htm", 
            "phone": "888-662-6728 (U.S. Only)"
        }, 
        "overall_official": {
            "affiliation": "Hoffmann-La Roche", 
            "last_name": "Clinical Trials", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "September 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Change in disease activity score 28-erythrocyte sedimentation rate (DAS28-ESR)", 
            "safety_issue": "No", 
            "time_frame": "24 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02001987"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Change in ACR/EULAR response", 
                "safety_issue": "No", 
                "time_frame": "24 weeks and up to 76 weeks"
            }, 
            {
                "measure": "Change in disease activity (CDAI/SDAI)", 
                "safety_issue": "No", 
                "time_frame": "24 weeks and up to 76 weeks"
            }, 
            {
                "measure": "Change in joint swelling/tenderness (SJC/TJC)", 
                "safety_issue": "No", 
                "time_frame": "24 weeks and up to 76 weeks"
            }, 
            {
                "measure": "Incidence of adverse events", 
                "safety_issue": "No", 
                "time_frame": "24 weeks and up to 76 weeks"
            }, 
            {
                "measure": "Changes in ultrasound assessment of joint inflammation (synovitis ultrasound scoring system)", 
                "safety_issue": "No", 
                "time_frame": "24 weeks"
            }, 
            {
                "measure": "Incidence of anti-therapeutic antibodies", 
                "safety_issue": "No", 
                "time_frame": "24 weeks and up to 76 weeks"
            }
        ], 
        "source": "Hoffmann-La Roche", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hoffmann-La Roche", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "February 2014", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}